Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
Monika D JoshiLeonard TuanquinJunjia ZhuVonn WalterTodd SchellMatthew KaagDeepak KilariJiangang LiaoSheldon L HolderHamid EmamekhooAlexander SankinSuzzane MerrillHong ZhengJoshua WarrickRalph HaukeBenjamin GartrelMark SteinJoseph DrabickDavid J DegraffYousef ZakhariaPublished in: Journal for immunotherapy of cancer (2023)
NCT02891161.
Keyphrases
- phase ii study
- locally advanced
- radiation therapy
- rectal cancer
- papillary thyroid
- urinary tract
- open label
- squamous cell carcinoma
- early stage
- spinal cord injury
- squamous cell
- radiation induced
- placebo controlled
- randomized controlled trial
- clinical trial
- lymph node metastasis
- young adults
- double blind
- study protocol